Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
JAMA Network Open|November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New ZealandDavid I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Cancers|February 25, 2023
Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)Jaidyn Muhandiramge, Erica T Warner, John R Zalcberg, et al.
Nature Reviews. Urology|July 24, 2020
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needsMichelle M Kouspou, Jenna E Fong, Nadine Brew, et al.
BJU International|October 17, 2013
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer RegistrySue M Evans, Jeremy L Millar, Mark Frydenberg, et al.
The Medical Journal of Australia|May 30, 2021
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare StandardsEva Segelov, Christine Carrington, Sanchia Aranda, et al.
Cancers|November 27, 2021
A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant DiseaseAndrew Bakshi, Moeen Riaz, Suzanne G Orchard, et al.
Clinical Genitourinary Cancer|February 9, 2022
Establishing metastatic prostate cancer quality indicators using a modified Delphi approachJia Zheng, Fanny Sampurno, Daniel J George, et al.
Journal of the American Medical Informatics Association : JAMIA|January 20, 2022
Knowledge and insights from a maturing international clinical quality registryFanny Sampurno, Christoph Kowalski, Sarah E Connor, et al.
The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
Pageof 9